Informed Consent

In a new study, Baylor College of Medicine researchers have raised ethical questions about clinical trials of deep brain stimulation (DBS) and other brain implants. "'Generally,...

“Two Scots whose lives have been ravaged by prescription drugs are battling for ­recognition of the devastating withdrawal issues as well as proper support for victims,”...

A new article explains common misconceptions about ADHD that are held by teachers and mental health professionals and may lead to overdiagnosis and overmedication in schools.

The Centers for Disease Control and Prevention (CDC) released new data indicating that as many as 75% of young children who are diagnosed with...

From The Atlantic: As opioid abuse rises, some attorneys general and advocates are filing lawsuits against pharmaceutical companies for misleading doctors and the public about...

Study details Medicaid-insured birth cohort’s exposure to psychiatric medications and mental health services.

From Alternet: Applications that provide online counseling, such as BetterHelp and Talkspace, are increasing in popularity. While some studies support the effectiveness of virtual therapy,...

Researchers report that dangerous side effects are not being adequately reported in the trials of ketamine for depression.

Changing the mental health and psychosocial support system in Germany requires public debate about the ways our society should help and support people in mental crisis and with chronic mental health problems. We believe the driving force behind all help and support should be humanitarianism and respect for inalienable human rights.

Despite concerns about the drug’s necessity, effectiveness, and side-effects, Flibanserin (Addyi) has come to market as the first drug designed to increase sexual desire in women

From FiercePharma: Vanda Pharmaceuticals, which makes the antipsychotic drug Fanapt, has recently rolled out a national TV campaign to raise awareness of akathisia. The company...

A large observational study published in CNS Drugs sheds light on serious adverse effects of the ‘gold standard’ antipsychotic Clozapine.

In a study published yesterday, researchers from the Nippon Medical School in Tokyo bring attention to a condition known as neuroleptic-induced deficit syndrome (NIDS)...

A new study in Psychiatric Services examines patient preferences for the myriad treatments available for Obsessive-compulsive disorder (OCD)

From Undark Magazine: In late 1970, a pharmacologist discovered that an antibiotic drug designed to cure a disease called SMON (subacute myelo-optic neuropathy) was actually causing...

When the CDC released data revealing an increasing suicide rate in the US, some experts, speaking to major media outlets, speculated that the increase...

Psychiatrist Julie Holland explains how antidepressants can medicate away important feelings and experiences in a video for Big Think. Video →

An exclusive analysis by CNN and researchers at Harvard University found that opioid manufacturers are paying physicians huge sums of money — and that doctors with higher...

Various instruments of the United Nations have commented on forced treatment, or involuntary confinement, or both (for details, see Burstow, 2015a), and a number of truly critical additions to international law have materialized. Arguably, the most significant of these is the Convention on the Rights of Persons with Disabilities. What makes it so significant? For one thing, it is because this landmark convention puts forward nothing less than a total ban on both involuntary treatment and the involuntary confinement of people who have broken no laws.

H. 3594 would require pharmacists to distribute pamphlets containing information on benzodiazepine misuse and abuse, risk of dependency and addiction, handling and addiction treatment resources. This would be a major legislative response to the prescribing patterns for these drugs today.

Members of the group Benzodiazepine Recovery have created a video to raise awareness for benzodiazepine withdrawal syndrome. It is estimated that 30 percent of people...

The Boston Herald reports on mental health care reform bills moving through both houses of Congress. Lawmakers warn, however, “that some aspects of the legislation could create greater barriers to access mental health care for some.”

In an op-ed for the Guardian, cardiologist Aseem Malhotra writes: “Corporate greed and systematic political failure have brought healthcare to its knees. There are too many misinformed doctors and misinformed patients. It’s time for greater transparency and stronger accountability, so that doctors and nurses can provide the best quality care for the most important person in the consultation room – the patient.”

From From Insults to Respect: It is commonly assumed that antidepressants increase the risk of suicide in children and young adults, but not in adults...

“Those who possess the data control the story.” In the wake of the reanalysis of the infamous Study 329, where scientific data claiming the antidepressant Paxil was safe and effective for teens was egregiously manipulated, researchers are pushing for open access to raw data. “The issue here, scientists argue, is that without independent confirmation, it becomes too easy to manipulate data.”